SCHEMBL25754931

SCHEMBL25754931

O=C(O)c1cnc(-c2cccs2)[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.58
ERCC1 P07992 4/20 0.50
FEN1 P39748 4/20 0.50
ERCC4 Q92889 4/20 0.50
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 7/20 0.43
HPGD P15428 3/20 0.43
PKM P14618 1/20 0.43
MAPT P10636 2/20 0.42
GRK6 P43250 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
NCOA1 Q15788 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057838 0.74 PIN1 (1.00) PIN1ERCC1FEN1ERCC4CYP1A2
SCHEMBL17269663 0.73 GAA (0.47) MEN1KMT2AKDM4EHPGDPKM
SCHEMBL13175051 0.72 SCN2A (0.62) MEN1KMT2AKDM4EHPGDMAPT
SCHEMBL497462 0.72 SLC7A5 (0.43) ERCC1FEN1ERCC4KDM4EHPGD
SCHEMBL28061565 0.72 SLC7A5 (0.43) ERCC1FEN1ERCC4KDM4EHPGD
SCHEMBL7565683 0.71 KMT2A (0.55) ERCC1FEN1ERCC4MEN1KMT2A
SCHEMBL25754942 0.71 PIN1 (0.63) PIN1DHODHDAO
SCHEMBL22027680 0.70 ERCC1 (0.68) PIN1ERCC1FEN1ERCC4MEN1
SCHEMBL1896303 0.69 PIN1 (0.65) PIN1KDM4EHPGDPKMALDH1A1
SCHEMBL25754920 0.69 SMN1; SMN2 (0.50) MEN1KMT2AKDM4EHPGDPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 PIN1 3482/4885ERCC1 3705/4885FEN1 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.